The global closed system transfer devices market was valued at USD 785.9 million in 2018 and is expected to reach USD 2,988.5 million in 2026, growing at a CAGR of 18.0% during the forecast period.
Worker exposure to chemotherapy and other hazardous drugs during preparation and administration has been a major concern for over decades. Guidelines for safer handling of these hazardous drugs are posed by the Oncology Nursing Society, the American Society of Health-System Pharmacists, among others. These healthcare groups have advocated personal protective equipment and safe work practices for reducing worker exposure to such hazardous drugs. CSTD can be considered as one such device that can play an increasing role in many health systems as part of an overall approach to reduce occupational exposure to hazardous drugs.
Get Sample Copy of Report at https://www.alltheresearch.com/sample-request/233
As per the report published by the World Health Organization (WHO), cancer is the second leading cause mortalities in 2018, with continuous rise in the number of cancer patient across the globe. Furthermore, it is estimated that one out of six deaths occurs due to cancer every year across the globe. As per WHO, nearly one-third of the mortalities from cancer are due to five leading behavioural and dietary risk, which includes low fruit and vegetable intake, high body mass index, lack of physical activity, alcohol consumption, and tobacco use. According to World Health Organization (WHO), in 2018, around 18.1 million cases of cancer and nearly 9.6 million mortalities were recorded across the globe. Such increasing prevalence of cancer is posing the requirement of safe and effective devices, such as CSTD, for reducing drug exposure.